NEOSETAC

The NEOSETAC project will demonstrate the anti-cancer therapeutic potential of a novel Selenium-based therapy for managing breast cancer. A recent clinical study shows that high selenium exposure could decrease cancer risk, especially high plasma/serum selenium and toenail selenium. NEOSETAC will demonstrate the potential of Selenium-based compounds to attack breast cancer cells; these compounds will be encapsulated in a targeted nanocapsule that will drive the compounds directly to the cancer cells. The overall research and development goal of the proposed action is twofold: to design and manufacture the Se-nanocapsules to treat breast cancer and demonstrate their therapeutic potential in pre-clinical studies.  REDINN role is leading Communication and Dissemination activities